Company / Capital Expenditures
Zomedica Corp. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$567.0K
FY2025
5-year range
$567.0K / $11.3M
FY2022-FY2025
Trend
-89.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $11M to $567,000 over the past 2 years.
Based on SEC 10-K filings.
$567,000 in FY2025 with a 3-year CAGR of -10.4%.
Declined from $11M to $567,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -10.4%, indicating a declining trend.
- In FY2025, capital expenditures decreased 89.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $567.0K | -89.1% |
| FY2024 | $5.2M | -54.0% |
| FY2023 | $11.3M | +1340.8% |
| FY2022 | $787.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026